Bioactivity | HBED dihydrochloride is an orally active and hexadentate phenolic aminocarboxylate iron chelator. HBED refers to N, N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid, inducing iron excretion in primates. HBED dihydrochloride has the potential to be used as an alternative to desferriamine for iron chelation therapy[1]. | ||||||||||||
In Vivo | HBED monohydrochloride dihydrate 在不同的给药方式下,产生的活性不同。HBED 以 81、162 和 324 μMol/kg 的剂量,口服给药后不会产生显著效果。而以 162 和 324 μMol/kg 的剂量,在皮下给药后,提高了净铁排泄量[1]。 | ||||||||||||
Name | HBED dihydrochloride | ||||||||||||
CAS | 35369-53-0 | ||||||||||||
Formula | C20H26Cl2N2O6 | ||||||||||||
Molar Mass | 461.34 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Bergeron RJ, et al. HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy. Blood. 1999 Jan 1;93(1):370-5. |